Global Point-of-Care Glucose Testing Market 2024 To 2033

Point-of-Care Glucose Testing Market Size, Trends and Insights By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer CONTOUR Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Others), By Technology (Glucose Oxidase Based Testing, Glucose Dehydrogenase Based Testing, Others), By Application (Type-1 Diabetes, Type-2 Diabetes), By End Users (Hospitals and Clinics, Home Care Settings, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the global Point-of-Care Glucose Testing Market is expected to record a CAGR of 4.5% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 3,670.9 Million. By 2033, the valuation is anticipated to reach USD 5,455.3 Million.

The Point-of-Care Glucose Testing Market involves the production and distribution of devices and systems for measuring blood glucose levels outside traditional laboratory settings, providing real-time results for diabetes management. Key components include blood glucose meters, continuous glucose monitoring systems, and associated consumables like testing strips and lancets.

This market serves healthcare facilities, home care settings, and diagnostic laboratories, driven by factors such as the increasing prevalence of diabetes, technological advancements in glucose monitoring devices, and the shift towards patient-centered care. Point-of-care glucose testing enables timely intervention, personalized treatment plans, and improved patient outcomes in diabetes management.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=54643